메뉴 건너뛰기




Volumn 81, Issue 2, 2013, Pages 364-369

Long-term outcomes and toxicity in patients treated with brachytherapy for prostate adenocarcinoma younger than 60 years of age at treatment with minimum 10 years of follow-up

Author keywords

[No Author keywords available]

Indexed keywords

IODINE 125; PALLADIUM 103; PHOSPHODIESTERASE V INHIBITOR;

EID: 84873292058     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2012.08.112     Document Type: Article
Times cited : (33)

References (19)
  • 1
    • 84862952700 scopus 로고    scopus 로고
    • Comparative analysis of prostate-specific antigen free survival outcomes for patients with low, intermediate and high risk prostate cancer treatment by radical therapy: Results from the Prostate Cancer Results Study Group
    • P. Grimm, I. Billiet, and D. Bostwick Comparative analysis of prostate-specific antigen free survival outcomes for patients with low, intermediate and high risk prostate cancer treatment by radical therapy: results from the Prostate Cancer Results Study Group BJU Int 109 suppl 1) 2012 22 29
    • (2012) BJU Int , vol.109 , Issue.SUPPL. 1 , pp. 22-29
    • Grimm, P.1    Billiet, I.2    Bostwick, D.3
  • 2
    • 40949147326 scopus 로고    scopus 로고
    • Quality of life and satisfaction with outcome among prostate-cancer survivors
    • M.G. Sanda, R.L. Dunn, and J. Michalski Quality of life and satisfaction with outcome among prostate-cancer survivors N Engl J Med 358 2008 1250 1261
    • (2008) N Engl J Med , vol.358 , pp. 1250-1261
    • Sanda, M.G.1    Dunn, R.L.2    Michalski, J.3
  • 3
    • 79960077352 scopus 로고    scopus 로고
    • 10-Year experience with I-125 prostate brachytherapy at the Princess Margaret Hospital: Results for 1,100 patients
    • J. Crook, J. Borg, and A. Evans 10-Year experience with I-125 prostate brachytherapy at the Princess Margaret Hospital: results for 1,100 patients Int J Radiat Oncol Biol Phys 80 2011 1323 1329
    • (2011) Int J Radiat Oncol Biol Phys , vol.80 , pp. 1323-1329
    • Crook, J.1    Borg, J.2    Evans, A.3
  • 4
    • 84858405681 scopus 로고    scopus 로고
    • Long-term toxicity and quality of life up to 10 years after low-dose rate brachytherapy for prostate cancer
    • A.M. Emara, E. Chadwick, and J.P. Nobes Long-term toxicity and quality of life up to 10 years after low-dose rate brachytherapy for prostate cancer BJU Int 109 2012 994 1000
    • (2012) BJU Int , vol.109 , pp. 994-1000
    • Emara, A.M.1    Chadwick, E.2    Nobes, J.P.3
  • 5
    • 83555160931 scopus 로고    scopus 로고
    • Factors influencing urinary symptoms 10 years after permanent prostate seed implantation
    • N.N. Stone, N.K. Gerber, and S. Blacksburg Factors influencing urinary symptoms 10 years after permanent prostate seed implantation J Urol 187 2012 117 123
    • (2012) J Urol , vol.187 , pp. 117-123
    • Stone, N.N.1    Gerber, N.K.2    Blacksburg, S.3
  • 6
    • 33847080897 scopus 로고    scopus 로고
    • Long-term urinary, sexual, and rectal morbidity in patients treated with iodine-125 prostate brachytherapy followed up for a minimum of 5 years
    • N.N. Stone, and R.G. Stock Long-term urinary, sexual, and rectal morbidity in patients treated with iodine-125 prostate brachytherapy followed up for a minimum of 5 years Urology 69 2007 338 342
    • (2007) Urology , vol.69 , pp. 338-342
    • Stone, N.N.1    Stock, R.G.2
  • 7
    • 79951989027 scopus 로고    scopus 로고
    • Impact of age at diagnosis on prostate cancer treatment and survival
    • S.K. Bechis, P.R. Carroll, and M.R. Cooperberg Impact of age at diagnosis on prostate cancer treatment and survival J Clin Oncol 29 2011 235 241
    • (2011) J Clin Oncol , vol.29 , pp. 235-241
    • Bechis, S.K.1    Carroll, P.R.2    Cooperberg, M.R.3
  • 8
    • 77950349543 scopus 로고    scopus 로고
    • Physician visits prior to treatment for clinically localized prostate cancer
    • T.L. Jang, J.E. Bekelman, and Y. Liu Physician visits prior to treatment for clinically localized prostate cancer Arch Intern Med 170 2010 440 450
    • (2010) Arch Intern Med , vol.170 , pp. 440-450
    • Jang, T.L.1    Bekelman, J.E.2    Liu, Y.3
  • 9
    • 81855194125 scopus 로고    scopus 로고
    • Treatment decision-making for localized prostate cancer: What younger men choose and why
    • A. Sidana, D.J. Hernandez, and Z. Feng Treatment decision-making for localized prostate cancer: what younger men choose and why Prostate 72 2012 58 64
    • (2012) Prostate , vol.72 , pp. 58-64
    • Sidana, A.1    Hernandez, D.J.2    Feng, Z.3
  • 10
    • 0038299194 scopus 로고    scopus 로고
    • Race independently predicts prostate specific antigen testing frequency following a prostate carcinoma diagnosis
    • S.B. Zeliadt, D.F. Penson, and P.C. Albertsen Race independently predicts prostate specific antigen testing frequency following a prostate carcinoma diagnosis Cancer 98 2003 496 503
    • (2003) Cancer , vol.98 , pp. 496-503
    • Zeliadt, S.B.1    Penson, D.F.2    Albertsen, P.C.3
  • 11
    • 30544440136 scopus 로고    scopus 로고
    • Biologically effective dose values for prostate brachytherapy: Effects on PSA failure and posttreatment biopsy results
    • R.G. Stock, N.N. Stone, J.A. Cesaretti, and B.S. Rosenstein Biologically effective dose values for prostate brachytherapy: effects on PSA failure and posttreatment biopsy results Int J Radiat Oncol Biol Phys 64 2006 527 533
    • (2006) Int J Radiat Oncol Biol Phys , vol.64 , pp. 527-533
    • Stock, R.G.1    Stone, N.N.2    Cesaretti, J.A.3    Rosenstein, B.S.4
  • 12
    • 33846632262 scopus 로고    scopus 로고
    • Assessment of postbrachytherapy sexual function: A comparison of the IIEF-5 and the MSEFS
    • T.M. Zagar, R.G. Stock, J.A. Cesaretti, and N.N. Stone Assessment of postbrachytherapy sexual function: a comparison of the IIEF-5 and the MSEFS Brachytherapy 6 2007 26 33
    • (2007) Brachytherapy , vol.6 , pp. 26-33
    • Zagar, T.M.1    Stock, R.G.2    Cesaretti, J.A.3    Stone, N.N.4
  • 13
    • 77950487153 scopus 로고    scopus 로고
    • Quality of life after open or robotic prostatectomy, cryoablation or brachytherapy for localized prostate cancer
    • J.B. Malcolm, M.D. Fabrizio, and B.B. Barone Quality of life after open or robotic prostatectomy, cryoablation or brachytherapy for localized prostate cancer J Urol 183 2010 1822 1828
    • (2010) J Urol , vol.183 , pp. 1822-1828
    • Malcolm, J.B.1    Fabrizio, M.D.2    Barone, B.B.3
  • 14
    • 77449084627 scopus 로고    scopus 로고
    • Health-related quality of life up to six years after (125)I brachytherapy for early-stage prostate cancer
    • E.M. Roeloffzen, I.M. Lips, and M.P. van Gellekom Health-related quality of life up to six years after (125)I brachytherapy for early-stage prostate cancer Int J Radiat Oncol Biol Phys 76 2010 1054 1060
    • (2010) Int J Radiat Oncol Biol Phys , vol.76 , pp. 1054-1060
    • Roeloffzen, E.M.1    Lips, I.M.2    Van Gellekom, M.P.3
  • 15
    • 0028835888 scopus 로고
    • Community-based population studies on the natural history of prostatism
    • S.J. Jacobsen, J.E. Oesterling, and M.M. Lieber Community-based population studies on the natural history of prostatism Curr Opin Urol 5 1995 13 17
    • (1995) Curr Opin Urol , vol.5 , pp. 13-17
    • Jacobsen, S.J.1    Oesterling, J.E.2    Lieber, M.M.3
  • 16
    • 84862776904 scopus 로고    scopus 로고
    • Long-term results of an RTOG Phase II trial (00-19) of external-beam radiation therapy combined with permanent source brachytherapy for intermediate-risk clinically localized adenocarcinoma of the prostate
    • C.A. Lawton, Y. Yan, and W.R. Lee Long-term results of an RTOG Phase II trial (00-19) of external-beam radiation therapy combined with permanent source brachytherapy for intermediate-risk clinically localized adenocarcinoma of the prostate Int J Radiat Oncol Biol Phys 82 2012 e795 e801
    • (2012) Int J Radiat Oncol Biol Phys , vol.82
    • Lawton, C.A.1    Yan, Y.2    Lee, W.R.3
  • 17
    • 84863438775 scopus 로고    scopus 로고
    • Long-term potency preservation following brachytherapy for prostate cancer
    • K.M. Snyder, R.G. Stock, M. Buckstein, and N.N. Stone Long-term potency preservation following brachytherapy for prostate cancer BJU Int 110 2012 221 225
    • (2012) BJU Int , vol.110 , pp. 221-225
    • Snyder, K.M.1    Stock, R.G.2    Buckstein, M.3    Stone, N.N.4
  • 18
    • 33846578156 scopus 로고    scopus 로고
    • Prevalence and risk factors for erectile dysfunction in the US
    • E. Selvin, A.L. Burnett, and E.A. Platz Prevalence and risk factors for erectile dysfunction in the US Am J Med 120 2007 151 157
    • (2007) Am J Med , vol.120 , pp. 151-157
    • Selvin, E.1    Burnett, A.L.2    Platz, E.A.3
  • 19
    • 83255164854 scopus 로고    scopus 로고
    • Prostate brachytherapy and second primary cancer risk: A competitive risk analysis
    • K.A. Hinnen, M. Schaapveld, and M. van Vulpen Prostate brachytherapy and second primary cancer risk: a competitive risk analysis J Clin Oncol 29 2011 4510 4515
    • (2011) J Clin Oncol , vol.29 , pp. 4510-4515
    • Hinnen, K.A.1    Schaapveld, M.2    Van Vulpen, M.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.